SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on its Phase 3 melanoma cancer-vaccine results and anticipation of fuller ESMO data, reinforced by CEO comments positioning the company as an mRNA platform spanning oncology and other diseases. Bulls point to the pipeline and momentum, while skeptics question the treatments broader efficacy, commercial scalability and valuation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys quarterly beat and raised full-year outlook, led by record QNX growth, are driving attention; traders are also focused on the QNX design wins involving Uber and Coretura. Bulls see momentum in automotive software and physical AI, while others question the muted, volatile post-earnings reaction and point to cautious near-term guidance and broader-market pressure.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions reported achievement of 30 entangled logical qubits on its Sqale commercial quantum system, using 80 physical qubits, is driving attention as a significant quantum-computing milestone. Many traders view it as validation of the companys neutral-atom approach, while others say the stocks muted, choppy reaction and broader market conditions temper the excitement.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos quarterly results beat expectations, but the shares barely moved as traders debated whether underlying sales momentum justifies the stocks premium valuation. Bulls pointed to resilient demand, while skeptics focused on the temporary tariff-refund benefit and questioned how earnings will look without it.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas Muse AI agent and expanded AI hardware and commerce integrations are driving enthusiasm around the companys AI strategy and a sharp share-price rally. Bulls see broad distribution and future monetization potential, while skeptics question Muses usefulness and revenue prospects and warn that the move is overextended.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais multibillion-dollar, seven-year cloud-capacity agreement with Anthropic is driving attention, with traders viewing it as a major validation of its AI infrastructure business. Others are wary of the associated stock warrants and heavy buildout spending, and discuss profit-taking after the sharp after-hours surge.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondos rally is being linked to institutional real-world-asset tokenization developments, including DTCC-related expansion and BlackRock-backed onchain portfolios. Bulls see these as evidence of growing adoption, while skeptics note that ONDO remains primarily a governance token and debate whether a future fee switch will deliver value to holders.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants availability on Robinhood is drawing attention as traders connect the listing to the tokens sharp move higher. Bulls see renewed access and QNTs limited supply as supportive, while others caution that the rally could fade or reflect short-term hype.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars steep selloff and fresh lows are being tied to analyst downgrades and limited visibility into near-term bookings, alongside solar-policy uncertainty and higher-rate concerns. Traders disagree on whether the move is an overreaction and buying opportunity or a sign of further weakness; some instead speculate about short-selling or China-related news without confirmation.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

SECZs sharp rally to fresh highs is drawing attention to Securitizes role in tokenizing financial assets, with traders treating the ARK Venture Fund tokenization as a sign of growing adoption. Bulls see the momentum as validation of the long-term tokenization theme, while others warn the run looks overheated and are taking profits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Discussion centers on the jury outcome in Nektars breach-of-contract case against Eli Lilly, with traders citing a reported roughly $90 million judgment. Reactions are divided: some see it as a win, while others consider the award disappointing relative to expectations and question what the jurys decision means for the case.

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN FRANCISCO, Aug. 28, 2026 SAN FRANCISCO, Aug. 28, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today...

Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis

Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in...

Nektar Q2 Earnings Beat Estimates, Revenues Lag, Pipeline in Focus

NKTR's Q2 earnings beat estimates, but revenues fall short. Investor focus stays on rezpeg as late-stage studies advance in autoimmune diseases.

Retail Sales Weaken in July

U.S. Stock Futures Mixed, Heads for a Winning Week

U.S. Stock Futures Mixed, Heads for a Winning Week.

Full Transcript: Nektar Therapeutics Q2 2026 Earnings Call

Nektar Therapeutics (NASDAQ:NKTR) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call.
This content is powered by Benzinga APIs. For comprehensive financial dataread more...

Nektar Therapeutics (NKTR) Reports Q2 Loss, Misses Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of +40.29% and -6.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nektar Therapeutics Announces Second Quarter 2026 Financial Results

Nektar Therapeutics Announces Second Quarter 2026 Financial Results Nektar Therapeutics Announces Second Quarter 2026 Financial Results PR Newswire SAN FRANCISCO, Aug. 13, 2026 SAN FRANCISCO, Aug. 13, 2026 /PRNewswire/ -- Nektar Therapeutics(Nasdaq: NKTR), a clinical-stage biotechnology company...

Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates

Journey Medical (DERM) delivered earnings and revenue surprises of 0.00% and -1.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm

Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm Kuehn Law Encourages Investors of Nektar Therapeutics to Contact Law Firm PR Newswire NEW YORK, Aug. 11, 2026 NEW YORK, Aug. 11, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NKTR Nektar Therapeutics

Fundamentals

Latest NKTR News